Target intelligence / Profile preview

Cytokine network

Molecular classification
Cytokine, Chemokine, Interleukin, Interferon, Tumor necrosis factor, Receptor
01

Overview

The cytokine network is a sophisticated intercellular communication system composed of small proteins called cytokines and their specific receptors, which coordinate the host immune response [1]. These molecules, including interleukins, interferons, and tumor necrosis factors, operate through complex signaling cascades to regulate cell growth, differentiation, and activation [2]. In a healthy state, the network maintains homeostasis; however, its dysregulation is central to the pathogenesis of autoimmune diseases, chronic inflammation, and the hyperinflammatory state known as a cytokine storm [3]. Pharmacological targeting of this network has revolutionized medicine, utilizing monoclonal antibodies and small molecule inhibitors to block specific cytokines or their downstream signaling pathways, such as the JAK-STAT pathway [4]. By modulating these pathways, clinicians can suppress pathological inflammation in conditions like rheumatoid arthritis and psoriasis while attempting to preserve overall immune competence [5]. Therapeutic strategies often focus on neutralizing ligands or blocking receptors to interrupt the positive feedback loops that drive chronic disease [1][6].

Other names
Immune system networkCytokine signaling systemInflammatory cytokine cascadeIntercellular signaling network
02

Mechanism of action

Therapeutic agents modulate the cytokine network by neutralizing soluble ligands, competitively inhibiting cell-surface receptors, or blocking intracellular signal transduction pathways like the JAK-STAT cascade [4][5].

03

Biological functions

Immune responseInflammationCell-to-cell communicationHematopoiesisApoptosisCell proliferation
04

Disease associations

Autoimmune diseaseCancerCytokine release syndromeChronic inflammationInfectionAllergy
05

Safety considerations

Increased risk of serious infectionsReactivation of latent tuberculosisMalignancy riskCytopeniaHepatotoxicity
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Cytokine network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call